European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs, Lissabon 2000, S. 3

Schließen Sie dieses Fenster um zum Text zurück zu gelangen.